CSSB and the UN-Supported Principles for Responsible Investment (PRI) to Host Sustainability Disclosure in Canada: Overcoming the Headwinds During Canada Climate Week Xchange — Neutral
XHG Newsfile Corp — November 18, 2025Toronto, Ontario--(Newsfile Corp. - November 18, 2025) - The Canadian Sustainability Standards Board (CSSB) and the UN-supported Principles for Responsible Investment (PRI) are hosting a live panel discussion, Sustainability Disclosure in Canada: Overcoming the Headwinds, as part of Canada Climate Week Xchange. Canadian sustainability reporting faces significant headwinds, but also major opportunities.
Gladstone Commercial: Series G Preferred Shares Look Attractive — Positive
GOOD Seeking Alpha — November 18, 2025Gladstone Commercial continues to grow its industrial portfolio, partially funding acquisitions with common stock issuance, while exhibiting robust occupancy. This incremental increase in common shares outstanding improves coverage for the company's preferred dividends. I estimate that the preferred shares could see meaningfully lower yields once the Fed is done with its policy normalization, perhaps as low as 5.79%.
Hercules Capital: Opportunity Knocks On This 11% Yield — Positive
HTGC Seeking Alpha — November 18, 2025Hercules Capital offers a compelling mix of high yield, strong credit quality, and steady growth, making it attractive for income investors. HTGC demonstrated strong results, including record new commitments and low non-accruals, highlighting disciplined management and portfolio strength. Despite trading at a premium to NAV, HTGC's forward P/E of 9.1 and fully covered 10.7% dividend yield underscore its earnings power and shareholder alignment.
Buying Netflix 10-for-1 Stock Split? Expect Underperformance — Negative
NFLX Schaeffers Research — November 18, 2025Netflix Inc (NASDAQ:NFLX) recently announced a 10-for-1 stock split, with trading on a split-adjusted basis set to begin next week.
Invivyd: Maintaining Hold Rating With VYD2311 Alternative To Covid-19 Vaccination — Positive
IVVD Seeking Alpha — November 18, 2025Invivyd, Inc. remains a Hold rating as it advances its monoclonal antibody pipeline, notably VYD2311 as a Covid-19 vaccine alternative. VYD2311 offers broader patient coverage and intramuscular dosing, with phase 3 DECLARATION and LIBERTY trials set to begin by end of 2025; Topline data mid-2026. Company's technology shows strong variant-neutralization, and expansion into RSV and measles prevention could unlock other market opportunities.
Moody's Corporation (MCO) Presents at J.P. Morgan 2025 Ultimate Services Investor Conference Transcript — Neutral
MCO Seeking Alpha — November 18, 2025Moody's Corporation ( MCO ) J.P. Morgan 2025 Ultimate Services Investor Conference November 18, 2025 1:20 PM EST Company Participants Robert Fauber - President, CEO & Director Conference Call Participants Andrew Steinerman - JPMorgan Chase & Co, Research Division Presentation Andrew Steinerman JPMorgan Chase & Co, Research Division Hi, everybody.
Paymentus Holdings, Inc. (PAY) Presents at Citi's 14th Annual FinTech Conference Transcript — Neutral
PAY Seeking Alpha — November 18, 2025Paymentus Holdings, Inc. ( PAY ) Citi's 14th Annual FinTech Conference November 18, 2025 10:30 AM EST Company Participants Sanjay Kalra - Senior VP, CFO & Principal Accounting Officer Dushyant Sharma - Chairman, President & CEO Conference Call Participants Peter Christiansen - Citigroup Inc. Exchange Research Presentation Peter Christiansen Citigroup Inc. Exchange Research Good morning. Welcome to Citi's 14th Annual Fintech Conference.
INSP Investors Have Opportunity to Lead Inspire Medical Systems, Inc. Securities Fraud Lawsuit — Neutral
INSP PRNewsWire — November 18, 2025NEW YORK , Nov. 18, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Inspire Medical Systems, Inc. (NYSE: INSP) between August 6, 2024 and August 4, 2025, both dates inclusive (the "Class Period"), of the important January 5, 2026 lead plaintiff deadline. So what: If you purchased Inspire Medical common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
Amazon Just Did This—and It Didn't End Well Last Time — Negative
AMZN MarketBeat — November 18, 2025For a stock that hit a fresh all-time high as recently as the start of November, it may come as a surprise that there's a bearish argument at all calling for a sell-off.
J.B. Hunt Transport Services, Inc. (JBHT) Presents at Stephens Annual Investment Conference 2025 Transcript — Neutral
JBHT Seeking Alpha — November 18, 2025J.B. Hunt Transport Services, Inc. ( JBHT ) Stephens Annual Investment Conference 2025 November 18, 2025 9:00 AM EST Company Participants Brad Delco - EVP of Finance & Chief Financial Officer Bradley Hicks - President of Dedicated Contract Services & Executive VP Conference Call Participants Brady Steven Lierz - Stephens Inc., Research Division Presentation Brady Steven Lierz Stephens Inc., Research Division All right. Well, good morning, everyone.
Pegasystems Inc. (PEGA) Presents at Global Technology, Internet, Media & Telecommunications Conference 2025 Transcript — Neutral
PEGA Seeking Alpha — November 18, 2025Pegasystems Inc. ( PEGA ) Global Technology, Internet, Media & Telecommunications Conference 2025 November 18, 2025 1:20 PM EST Company Participants Kenneth Stillwell - COO & CFO Conference Call Participants Rishi Jaluria - RBC Capital Markets, Research Division Presentation Rishi Jaluria RBC Capital Markets, Research Division [Audio Gap] I cover software here at RBC. I'm delighted to have with me Ken Stillwell, who is the CFO and COO of Pega.
WestJet Airlines CEO sees progress on Boeing 737 MAX 10 certification, rolls out non-US routes — Positive
BA Reuters — November 18, 2025WestJet Airlines remains on track to take its first 737 MAX 10 jet by the end of 2026, following progress by Boeing in bringing the plane to market, as the Canadian carrier also adds new routes to South America and Europe, its CEO said on Tuesday.
ROSEN, HIGHLY RANKED INVESTOR COUNSEL, Encourages Stride, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - LRN — Neutral
LRN Newsfile Corp — November 18, 2025New York, New York--(Newsfile Corp. - November 18, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of Stride, Inc. (NYSE: LRN) between October 22, 2024 and October 28, 2025, both dates inclusive (the "Class Period"). A class action lawsuit has already been filed.
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Telix Pharmaceuticals Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - TLX — Neutral
TLX Newsfile Corp — November 18, 2025New York, New York--(Newsfile Corp. - November 18, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of securities of Telix Pharmaceuticals Ltd. (NASDAQ: TLX) between February 21, 2025 and August 28, 2025, both dates inclusive (the "Class Period").
iShares Global Timber & Forestry ETF: The Worst May Be Yet To Come — Neutral
WOOD Seeking Alpha — November 18, 2025I am concluding my research on the forest industry with the iShares Global Timber & Forestry ETF. The companies I have previously covered account for ~25% of WOOD's 225.6 million AUM. The Invesco MSCI Global Timber ETF is WOOD's closest competitor, with a $41.2 million AUM. Smaller size is synonymous with thinner liquidity, as reflected by a higher median bid-ask spread. Despite lower liquidity, CUT's total expense ratio of 1.02% is ~2.5x higher than WOOD's 0.40%. Considering their highly similar portfolios, it is difficult to justify such a spread.
KMX CLASS NOTICE: BFA Law Alerts CarMax, Inc. Investors of the Pending Securities Fraud Class Action and Upcoming January 2 Deadline — Neutral
KMX Newsfile Corp — November 18, 2025New York, New York--(Newsfile Corp. - November 18, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against CarMax, Inc. (NYSE: KMX) and certain of the Company's senior executives for securities fraud after a significant stock drop resulting from the potential violations of the federal securities laws. If you invested in CarMax, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/carmax-inc-class-action-lawsuit.
JHX CLASS NOTICE: BFA Law Alerts James Hardie Industries plc Investors of the Pending Securities Fraud Class Action and Upcoming December 23 Deadline — Neutral
JHX Newsfile Corp — November 18, 2025New York, New York--(Newsfile Corp. - November 18, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against James Hardie Industries plc (NYSE: JHX) and certain of the Company's senior executives for securities fraud after a significant stock drop resulting from the potential violations of the federal securities laws. If you invested in James Hardie, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/james-hardie-industries-class-action-lawsuit.
INSP CLASS NOTICE: BFA Law Alerts Inspire Medical Systems, Inc. Investors of the Pending Securities Fraud Class Action and Upcoming January 5 Deadline — Neutral
INSP Newsfile Corp — November 18, 2025New York, New York--(Newsfile Corp. - November 18, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Inspire Medical Systems, Inc. (NYSE: INSP) and certain of the Company's senior executives for securities fraud after a significant stock drop resulting from the potential violations of the federal securities laws. If you invested in Inspire, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/inspire-medical-systems-inc-class-action-lawsuit.
MLTX CLASS NOTICE: BFA Law Alerts MoonLake Immunotherapeutics Investors of the Pending Securities Fraud Class Action and Upcoming December 15 Deadline — Neutral
MLTX Newsfile Corp — November 18, 2025New York, New York--(Newsfile Corp. - November 18, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against MoonLake Immunotherapeutics (NASDAQ: MLTX) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in MoonLake, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/moonlake-immunotherapeutics-class-action-lawsuit.
LRN CLASS NOTICE: BFA Law Alerts Stride, Inc. Investors of the Pending Securities Fraud Class Action and Upcoming January 12 Deadline — Neutral
LRN Newsfile Corp — November 18, 2025New York, New York--(Newsfile Corp. - November 18, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Stride, Inc. (NYSE: LRN) and certain of the Company's senior executives for securities fraud after significant stock drops resulting from the potential violations of the federal securities laws. If you invested in Stride, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/stride-inc-class-action-lawsuit.